Hologic Balance Sheet Health

Financial Health criteria checks 6/6

Hologic has a total shareholder equity of $4.8B and total debt of $2.5B, which brings its debt-to-equity ratio to 52.9%. Its total assets and total liabilities are $8.7B and $4.0B respectively. Hologic's EBIT is $977.6M making its interest coverage ratio 45.3. It has cash and short-term investments of $2.0B.

Key information

52.9%

Debt to equity ratio

US$2.53b

Debt

Interest coverage ratio45.3x
CashUS$1.97b
EquityUS$4.77b
Total liabilitiesUS$3.96b
Total assetsUS$8.73b

Recent financial health updates

Recent updates

Is Hologic (NASDAQ:HOLX) A Risky Investment?

Jan 31
Is Hologic (NASDAQ:HOLX) A Risky Investment?

Hologic: Reasonably, But Not Compellingly Valued

Jan 17

Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return

Jan 13
Here's What To Make Of Hologic's (NASDAQ:HOLX) Decelerating Rates Of Return

Earnings Not Telling The Story For Hologic, Inc. (NASDAQ:HOLX)

Dec 22
Earnings Not Telling The Story For Hologic, Inc. (NASDAQ:HOLX)

Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 60% Above Its Share Price

Dec 04
Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 60% Above Its Share Price

When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Nov 02
When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Hologic: Continued Room Amidst Bolt-On M&A Efforts

Oct 28

Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Oct 17
Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Sep 16
Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Sep 01
Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them

Aug 27

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

Jul 21
Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Jun 20
These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

May 22
Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

Hologic: Women's Health Play Looks Healthier Itself

May 13

Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Apr 19
Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Apr 05
Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Mar 20
Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Feb 22
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Hologic: Prospects For Growth As Headwinds Disappear

Feb 11

We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Feb 09
We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Financial Position Analysis

Short Term Liabilities: HOLX's short term assets ($3.5B) exceed its short term liabilities ($1.0B).

Long Term Liabilities: HOLX's short term assets ($3.5B) exceed its long term liabilities ($3.0B).


Debt to Equity History and Analysis

Debt Level: HOLX's net debt to equity ratio (11.6%) is considered satisfactory.

Reducing Debt: HOLX's debt to equity ratio has reduced from 136.1% to 52.9% over the past 5 years.

Debt Coverage: HOLX's debt is well covered by operating cash flow (49.7%).

Interest Coverage: HOLX's interest payments on its debt are well covered by EBIT (45.3x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 23:56
End of Day Share Price 2025/02/06 00:00
Earnings2024/12/28
Annual Earnings2024/09/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hologic, Inc. is covered by 51 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Ishan MajumdarBaptista Research
Charles ButlerBarclays